Skip to main content
Lindsey Bordone, MD, Dermatology, New York, NY

Lindsey Alexis Bordone MD FAAD

Acne & Rosacea


Dermatologist at Columbia University-NYP

Request Appointment
  • 51 W 51st StSuite 390New York, NY 10019

  • Book by Phone+1(234) 595-2049

  • Fax+1 212-326-8567

Overview of  Dr. Bordone

Dr. Lindsey Bordone is a dermatologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 8 years. She is one of 276 doctors at New York-Presbyterian Hospital and one of 123 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Dermatology. She has more than 20 publications and over 400 citings.

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiResidency, Dermatology, 2011 - 2014
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2009 - 2011
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 2009

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2023 - Present
  • NY State Medical License
    NY State Medical License 2013 - 2027
  • NJ State Medical License
    NJ State Medical License 2014 - 2025
  • CO State Medical License
    CO State Medical License 2019 - 2021
  • Dermatology
    American Board of Dermatology Dermatology

Publications & Presentations

PubMed

Press Mentions

  • Dermatologists as Obesity’s Primary Care Physicians | AAD 2025
    Dermatologists as Obesity’s Primary Care Physicians | AAD 2025March 12th, 2025
  • Transform Your Skin Health: Diet and Lifestyle Take Center Stage at 2025 AAD Annual Meeting
    Transform Your Skin Health: Diet and Lifestyle Take Center Stage at 2025 AAD Annual MeetingMarch 4th, 2025
  • FDA Approves Drug Sotyktu for Treatment of Plaque Psoriasis
    FDA Approves Drug Sotyktu for Treatment of Plaque PsoriasisSeptember 10th, 2022
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: